BioSpace News Archive

According to the business intelligence study, the global big data in healthcare market is set to grow, featuring a significant growth rate of 19.1 % over the forecast period i.e. 2018 to 2025.

Albany NY, United States: The global spinal machined bone allograft market is projected to witness significant growth from 2021 to 2031.

Albany NY, United States: The global ramipril market is anticipated to expand at a promising rate from 2021 to 2031.

DUBAI, United Arab Emirates, Growing number of diabetics in the US, Canada and European countries has been compelling hospitals to keep artificial pancreas systems in stock.

Curium confirmed no supply challenges of 177Lu-PSMA-I&T for the Phase 3 ECLIPSE clinical trial, evaluating Lutetium 177Lu-PSMA-I&T treatment compared to the standard of care hormone therapy in men with metastatic Castration-Resistant Prostate Cancer.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of Sensorion’s management in two scientific conferences being held in May 2022.

Cullinan Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. announced an agreement through which Taiho will acquire Cullinan Pearl Corp. and co-develop and co-commercialize Cullinan Oncology’s lead program, CLN-081/TAS6417, an orally available, differentiated, irreversible EGFR inhibitor that selectively targets cells expressing EGFR exon 20 insertion mutations while sparing cells expressing wild-type EGFR.

Poolbeg Pharma announces an update on its lead asset, POLB 001, a small molecule immunomodulator which aims to address a significant unmet need in severe influenza.

Machine perfusion for lungs and livers is now being reimbursed in the Dutch healthcare system.

Therapixel, designer and supplier of MammoScreen® an Artificial Intelligence software reading aid for mammography, announces fundraising of 15 M€ in series B.